Tyrosines in the Influenza A Virus M2 Protein Cytoplasmic Tail Are Critical for Production of Infectious Virus Particles

W Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University, Bloomberg School of Public Health, 615 North Wolfe Street, Suite 5132, Baltimore, Maryland 21205, USA.
Journal of Virology (Impact Factor: 4.44). 09/2010; 84(17):8765-76. DOI: 10.1128/JVI.00853-10
Source: PubMed


The cytoplasmic tail of the influenza A virus M2 protein is required for the production of infectious virions. In this study,
critical residues in the M2 cytoplasmic tail were identified by single-alanine scanning mutagenesis. The tyrosine residue
at position 76, which is conserved in >99% of influenza virus strains sequenced to date, was identified as being critical
for the formation of infectious virus particles using both reverse genetics and a protein trans-complementation assay. Recombinant viruses encoding M2 with the Y76A mutation demonstrated replication defects in MDCK cells
as well as in primary differentiated airway epithelial cell cultures, defects in the formation of filamentous virus particles,
and reduced packaging of nucleoprotein into virus particles. These defects could all be overcome by a mutation of serine to
tyrosine at position 71 of the M2 cytoplasmic tail, which emerged after blind passage of viruses containing the Y76A mutation.
These data confirm and extend our understanding of the significance of the M2 protein for infectious virus particle assembly.

Download full-text


Available from: Andrew Pekosz,
  • Source
    • "M2e5× VLPs that contain a tandem repeat of M2e sequences derived from human (2×), swine (1×) and avian (2×) influenza viruses were produced as previously described [11]. The M2 expressing MDCK cell line was kindly provided by Dr. Andrew Pekosz [15] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Immunity in humans with annual vaccination does not provide effective protection against antigenically distinct strains. As an approach to improve cross-protection in the presence of pre-existing strain-specific immunity, we investigated the efficacy of heterologous and heterosubtypic protection in previously vaccinated mice at earlier times after subsequent immunization with conserved-antigenic target influenza M2 ectodomain (M2e) virus-like particle vaccine (M2e5× VLP). Immunization of mice with H1N1 split vaccine induced virus specific antibodies to homologous influenza virus but did not provide heterosubtypic hemagglutination inhibiting antibody responses and cross-protection. However, subsequent M2e5× VLP immunization induced M2e specific antibody response as well as interferon-γ (IFN-γ) producing cells in systemic and mucosal sites. Upon lethal challenge with H3N2 or H5N1 subtype influenza viruses, subsequently immunized mice with M2e5× VLP were well protected against heterosubtypic influenza viruses. These results provide evidence that non-seasonal immunization with M2e5× VLP, an experimental candidate for universal vaccine, is a promising approach for broadening the cross-protection even in the presence of strain-specific immunity.
    Vaccine 08/2014; 32(44). DOI:10.1016/j.vaccine.2014.08.030 · 3.62 Impact Factor
  • Source
    • "The M2 cytoplasmic tail was also shown to be important for the efficient production of infectious viral particles , as mutations between residues 70 – 77 impaired vRNP incorporation into budding virions ( Grantham et al . , 2010 ; McCown and Pekosz , 2005 ; McCown and Pekosz , 2006 ) . However , it is not known if the cytoplasmic tail of M2 binds NP directly or if alterations in the M2 - M1 interaction are responsible for the reduction in vRNP packaging . Additional evidence for the interaction between M2 and M1 comes from the observation that treatment of influ"
    [Show abstract] [Hide abstract]
    ABSTRACT: Influenza A virus causes seasonal epidemics, sporadic pandemics and is a significant global health burden. Influenza virus is an enveloped virus that contains a segmented negative strand RNA genome. Assembly and budding of progeny influenza virions is a complex, multi-step process that occurs in lipid raft domains on the apical membrane of infected cells. The viral proteins hemagglutinin (HA) and neuraminidase (NA) are targeted to lipid rafts, causing the coalescence and enlargement of the raft domains. This clustering of HA and NA may cause a deformation of the membrane and the initiation of the virus budding event. M1 is then thought to bind to the cytoplasmic tails of HA and NA where it can then polymerize and form the interior structure of the emerging virion. M1, bound to the cytoplasmic tails of HA and NA, additionally serves as a docking site for the recruitment of the viral RNPs and may mediate the recruitment of M2 to the site of virus budding. M2 initially stabilizes the site of budding, possibly enabling the polymerization of the matrix protein and the formation of filamentous virions. Subsequently, M2 is able to alter membrane curvature at the neck of the budding virus, causing membrane scission and the release of the progeny virion. This review investigates the latest research on influenza virus budding in an attempt to provide a step-by-step analysis of the assembly and budding processes for influenza viruses.
    Virology 03/2011; 411(2):229-36. DOI:10.1016/j.virol.2010.12.003 · 3.32 Impact Factor

Show more